TriSalus Life Sciences, Inc. Common Stock earnings per share and revenue
On Jan 12, 2026, TLSI reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.13 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 13.17 million, with a --% difference. The market reacted with a +1.21% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tilray Brands, Inc. Common Stock
Report Date
Jan 08, 2026 For Q2 26
Estimate
-$0.20
Actual
-$0.41
Surprise
-100.98%
Neogen Corp
Report Date
Jan 08, 2026 For Q2 26
Estimate
$0.05
Actual
$0.10
Surprise
+78.25%
FAQ
What were TriSalus Life Sciences, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, TriSalus Life Sciences, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to TriSalus Life Sciences, Inc. Common Stock's Q4 2025 earnings?
The stock price moved up 1.21%, changed from $5.80 before the earnings release to $5.87 the day after.
When is TriSalus Life Sciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for TriSalus Life Sciences, Inc. Common Stock's next earnings report?
Based on --
analysts, TriSalus Life Sciences, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.